BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11322374)

  • 1. Renal tubular dysfunction in epileptic children on valproic acid therapy.
    Altunbaşak S; Yildizaş D; Anarat A; Burgut HR
    Pediatr Nephrol; 2001 Mar; 16(3):256-9. PubMed ID: 11322374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine].
    Hurkacz M; Wiela-Hojeńska A; Orzechowska-Juzwenko K; Kozik A; Unolt J
    Pol Merkur Lekarski; 2001 Dec; 11(66):480-3. PubMed ID: 11899842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of renal proximal tubular dysfunction with Fanconi syndrome caused by sodium valproate.
    Yamazaki S; Watanabe T; Sato S; Yoshikawa H
    Pediatr Int; 2016 Oct; 58(10):1023-1026. PubMed ID: 26896192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for sodium valproate-induced renal tubular dysfunction.
    Koga S; Kimata T; Yamanouchi S; Tsuji S; Yoshimura K; Araki A; Kaneko K
    Clin Exp Nephrol; 2018 Apr; 22(2):420-425. PubMed ID: 28836089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tubular function in patients receiving anticonvulsant therapy: a long-term study.
    Verrotti A; Greco R; Pascarella R; Matera V; Morgese G; Chiarelli F
    Epilepsia; 2000 Nov; 41(11):1432-5. PubMed ID: 11077456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypouricemia in severely disabled children: influence of valproic acid and bed-ridden state.
    Yoshikawa H; Yamazaki S; Watanabe T; Abe T
    Brain Dev; 2003 Apr; 25(3):186-90. PubMed ID: 12689697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tubular dysfunction following treatment with anti-epileptic drugs.
    Korinthenberg R; Wehrle L; Zimmerhackl LB
    Eur J Pediatr; 1994 Nov; 153(11):855-8. PubMed ID: 7843203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal tubular dysfunction measured by N-acetyl-beta glucosaminidase/Creatinine activity index in children receiving antiepileptic drugs: a randomized controlled trial.
    Mazaheri M; Samaie A; Semnani V
    Ital J Pediatr; 2011 May; 37():21. PubMed ID: 21569539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fanconi syndrome caused by antiepileptic therapy with valproic Acid.
    Knorr M; Schaper J; Harjes M; Mayatepek E; Rosenbaum T
    Epilepsia; 2004 Jul; 45(7):868-71. PubMed ID: 15230715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-induced proximal renal tubular dysfunction: clinically relevant in the severely disabled epileptic population.
    Jaffe SL; Sanford M
    Epilepsia; 2005 Apr; 46(4):599-600. PubMed ID: 15816962
    [No Abstract]   [Full Text] [Related]  

  • 11. Fanconi syndrome caused by valproic acid.
    Endo A; Fujita Y; Fuchigami T; Takahashi S; Mugishima H
    Pediatr Neurol; 2010 Apr; 42(4):287-90. PubMed ID: 20304335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase by patients with epilepsy.
    Novo Mde L; Izumi T; Yokota K; Fukuyama Y
    Brain Dev; 1993; 15(2):157-60. PubMed ID: 8214337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary renal Fanconi syndrome caused by valproate therapy.
    Watanabe T; Yoshikawa H; Yamazaki S; Abe Y; Abe T
    Pediatr Nephrol; 2005 Jun; 20(6):814-7. PubMed ID: 15785938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubular dysfunction in extremely low birth weight survivors.
    Matsumura K; Matsuzaki Y; Hida M; Ikeda K; Awazu M
    Clin Exp Nephrol; 2019 Mar; 23(3):395-401. PubMed ID: 30238383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal dysfunctions/injury in adult epilepsy patients treated with carbamazepine or valproate.
    Hamed SA; Rageh TA; Mohamad AO; Abou Elnour SM
    Expert Rev Clin Pharmacol; 2018 Aug; 11(8):819-824. PubMed ID: 30009654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Biopsy Findings in a Patient With Valproic Acid-Associated Fanconi Syndrome.
    Singer P; Sethna CB; Castellanos-Reyes L; Yaskiv O; Bijol V
    Pediatr Dev Pathol; 2019; 22(4):370-374. PubMed ID: 30565480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fanconi syndrome caused by sodium valproate: report of three severely disabled children.
    Yoshikawa H; Watanabe T; Abe T
    Eur J Paediatr Neurol; 2002; 6(3):165-7. PubMed ID: 12363104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of sodium valproate on the renal function of children with epilepsy.
    Knights MJ; Finlay E
    Pediatr Nephrol; 2014 Jul; 29(7):1131-8. PubMed ID: 23720013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of renal tubular function in children taking anti-epileptic treatment.
    Unay B; Akin R; Sarici SU; Gok F; Kurt I; Gokcay E
    Nephrology (Carlton); 2006 Dec; 11(6):485-8. PubMed ID: 17199783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid.
    Nisha Y; Bobby Z; Wadwekar V
    Seizure; 2018 Aug; 60():57-60. PubMed ID: 29906708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.